Comparing and Analyzing Russian, UK, and US Top Ten Pharma Inspection Findings FY 2019

Presented on October 29th, 2020

Download our webinar comparing inspection findings across Russia, the UK, and the US, which reveals several similarities and a few differences. This session will be valuable to anyone responsible for regulatory inspections and interacting directly with global regulatory investigators during inspections. Key takeaways:

• A comparison of 483 observations in FY2019
• Top 10 Russian Ministry of Health inspection findings
• Top 10 FDA Warning Letter findings
• Top MHRA inspection findings